Padriac Hooper1,2, Monique Tourell1,2, Kieran O'Brien2,3, Jin Jin2,3, Simon Daniel Robinson1,4,5,6, and Markus Barth1,2,7
1Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia, 2ARC Training Centre for Innovation in Biomedical Imaging Technology, Brisbane, Australia, 3Siemens Healthcare Pty Ltd, Brisbane, Australia, 4High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria, 5Karl Landsteiner Institute for Clinical Molecular MR in Musculoskeletal Imaging, Vienna, Austria, 6Department of Neurology, Medical University of Graz, Graz, Austria, 7School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Australia
Synopsis
The phantom was developed to cover the full range of physiological
and pathological magnetic susceptibility seen in iron- and calcium-containing
tissue, using 4 materials within the one phantom. The phantom facilitates
quality assurance for acquisition strategies and post-processing tools.
INTRODUCTION
QSM provides improved detection and differentiation of iron and calcium
deposits compared to susceptibility weighted imaging (1), which is important
for the diagnosis of neurodegenerative diseases such as Alzheimer’s (2), intracranial haemorrhage
staging (3) and brain tumours (4). Due to its complexity, the clinical and MR research
communities are actively investigating validation approaches for QSM to verify how
the data is acquired, and the uncertainty in how images are post-processed. There
are a number of QSM phantoms proposed to date (5–7), yet no one phantom covers the full
range of physiological and pathological magnetic susceptibility seen in iron-
and calcium-containing tissue (8,9). The project aims to design
and prototype such a phantom, facilitating quality assurance for acquisition
strategies and post-processing tools for QSM.METHODS
Phantom construction: The phantom (cylinder with outer dimensions: 140 mm
diameter, 220 mm length, see cross-section in figure 1) was filled with
deionized water and Magnevist (0.29 mmol/L). 18 vials (10 mm diameter) were
added, filled with a gel (1.5 wt.% low-melting-point agarose heated to 60°C),
and one of the 4 materials with varied concentrations (figure 1). The
concentrations were chosen to cover a wide physiological and pathological range
of iron- and calcium-containing tissue (8,9).
The gel was microwaved in a conical flask and inspected
under light to detect clumps within the gel to ensure that the iron and/or
calcium had not agglomerated. Bubbles were removed by swirling within the
conical flask and over-filling the NMR tube, prior to sealing with the cap. The imaging volume and the fill port volume were separated by an acrylic
disk, preventing potential air bubble diffusion into the imaging space. Each vial was positioned ≥ 9 mm away from
each other, and ≥ 9 mm away from the phantom periphery.
MRI data acquisition: magnitude and phase data were acquired
using a bipolar multi-echo GRE acquisition (figure 2) on a 3 Tesla scanner (Magnetom
Prisma, Siemens Healthcare, Erlangen, Germany).
QSM reconstruction: coil combination and unwrapping: ASPIRE (10), ROMEO (11); multi-echo combination: unweighted
fitting of the unwrapped phase; background field removal: LBV (12); dipole inversion: MEDI (13). The first echo was set as
the template for temporal unwrapping (11), and eddy current phase
offsets were corrected (10).
Image analysis: Cylindrical ROIs (7 mm) were defined on the magnitude image for each
vial in ImageJ over 30 slices about the isocentre, excluding Gibbs’ ringing,
partial volume effects at vial boundaries and aliasing artefacts at distal
slices. The phase offset ($$$ψ_0$$$) was measured by fitting the unwrapped
phase against echo time ($$$ψ = ψ(TE) + ψ_0$$$). R2* map:
fast numerical method NumART2* from the magnitude data (14).RESULTS & DISCUSSION
There is visible contrast in the total field, local field
and QSM for all iron-based materials, as can be seen in Figure 2. The total
field, and to a lesser extent the local field and QSM show inhomogeneities about
the phantom periphery. The local field and QSM contrast appear similar.
There are a range of factors that might influence a χ-value estimate by QSM. Figure
3 shows that our χ-value
estimate by QSM were overestimated by between 5 to 15 % when compared to the
analytical χ-value
estimate (15); which might be attributed to
incomplete background field removal. External reference measurements (e.g.,
using SQUIDs) could provide further validation. Figure 4 (left and right) shows
that our χ-value estimate
by QSM is higher compared to other χ-value estimates by QSM (5–7); which might be attributed to
differences in acquisition strategies and post-processing parameters. The χ-value estimates for calcium
chloride were a factor of 4 lower than literature (7): -0.009 ppm / wt.% CaCl2,
likely due to the use of a different solute (granular calcium chloride) as a
basis for the gel mixture.
In general, QSM phantom studies need to consider spatial
dependencies. Phase offsets might be larger about higher iron concentrations,
shown in figure 5. Future phantom designs should integrate multiple samples of
the same concentration at different locations.CONCLUSION
This phantom shows promise to be able to critically assess
and verify QSM acquisition strategies and post-processing tools. The phantom
can be improved by utilizing more vials of the same concentration distributed
across the phantom to reduce potential bias from spatial dependencies.Acknowledgements
We thank
the CAI workshop staff for designing and machining the phantom.References
1.
Soman S, Lee K, Selim M,
Filippidis A, Thomas A, Spincemaille P, et al. Improved Cerebral Microbleed vs
Calcification Discrimination using QSM compared to SWI Phase Maps. In:
Proceedings of International Society of Magnetic Resonance in Medicine. Virtual
Conference; 2020.
2. Ravanfar
P, Loi SM, Syeda WT, Van Rheenen TE, Bush AI, Desmond P, et al. Systematic
Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in
Neurodegenerative Diseases. Front Neurosci. 2021 Feb 18;15:618435.
3. Chang
S, Zhang J, Liu T, Tsiouris AJ, Shou J, Nguyen T, et al. Quantitative
Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages. J Magn
Reson Imaging. 2016 Aug;44(2):420–5.
4. Deistung
A, Schweser F, Wiestler B, Abello M, Roethke M, Sahm F, et al. Quantitative Susceptibility
Mapping Differentiates between Blood Depositions and Calcifications in Patients
with Glioblastoma. Kleinschnitz C, editor. PLoS ONE. 2013 Mar 21;8(3):e57924.
5. Kim
J-H, Kim J-H, Lee S-H, Park J, Lee S-K. Fabrication of a spherical inclusion
phantom for validation of magnetic resonance-based magnetic susceptibility
imaging. Deniz CM, editor. PLOS ONE. 2019 Aug 5;14(8):e0220639.
6. Xie H,
Cheng Y-CN, Kokeny P, Liu S, Hsieh C-Y, Haacke EM, et al. A quantitative study
of susceptibility and additional frequency shift of three common materials in
MRI: A Quantitative Study of Susceptibility and Additional Frequency Shift.
Magn Reson Med. 2016 Oct;76(4):1263–9.
7. Cheng
Y-CN. Development and Testing of Iron Based Phantoms as Standards for the Diagnosis
of Microbleeds and Oxygen Saturation with Applications in Dementia, Stroke, and
Traumatic Brain Injury: [Internet]. Detroit, Michigan: Defense Technical
Information Center; 2013 Oct [cited 2021 Nov 1]. Report No.: ADA601806.
Available from: https://apps.dtic.mil/sti/citations/ADA601806
8. Oshima
S, Fushimi Y, Okada T, Takakura K, Liu C, Yokota Y, et al. Brain MRI with
Quantitative Susceptibility Mapping: Relationship to CT Attenuation Values.
Radiology. 2020 Mar;294(3):600–9.
9. Sun H,
Klahr AC, Kate M, Gioia LC, Emery DJ, Butcher KS, et al. Quantitative
Susceptibility Mapping for Following Intracranial Hemorrhage. Radiology. 2018
Sep;288(3):830–9.
10. Eckstein
K, Dymerska B, Bachrata B, Bogner W, Poljanc K, Trattnig S, et al.
Computationally Efficient Combination of Multi-channel Phase Data From
Multi-echo Acquisitions (ASPIRE). Magn Reson Med. 2018 Jun;79(6):2996–3006.
11. Dymerska
B, Eckstein K, Bachrata B, Siow B, Trattnig S, Shmueli K, et al. Phase
unwrapping with a rapid opensource minimum spanning tree algorithm (ROMEO).
Magn Reson Med. 2021 Apr;85(4):2294–308.
12. Zhou D,
Liu T, Spincemaille P, Wang Y. Background field removal by solving the
Laplacian boundary value problem. NMR Biomed. 2014 Mar;27(3):312–9.
13. Liu J,
Liu T, de Rochefort L, Ledoux J, Khalidov I, Chen W, et al. Morphology enabled
dipole inversion for quantitative susceptibility mapping using structural
consistency between the magnitude image and the susceptibility map. NeuroImage.
2012 Feb;59(3):2560–8.
14. Hagberg
GE, Bianciardi M, Patria F, Indovina I. Quantitative NumART2* mapping in
functional MRI studies at 1.5 T. Magn Reson Imaging. 2003 Dec;21(10):1241–9.
15. Schenck
JF. Health and Physiological Effects of Human Exposure to Whole-Body Four-Tesla
Magnetic Fields during MRI. Ann N Y Acad Sci. 1992 Mar;649(1 Biological
Ef):285–301.